

Paroxetine
Paroxetine is used for treating depression or obsessive-compulsive disorder (OCD).
Similar products


Detrol (tolterodine tartrate) is a prescription medication specifically formulated to manage the symptoms of overactive bladder (OAB). As an antimuscarinic agent, it works by relaxing the bladder muscle, thereby reducing urinary urgency, frequency, and episodes of urge incontinence. This medication is designed to help restore a sense of normalcy and control, allowing patients to engage in daily activities with greater confidence and comfort. Clinical studies support its efficacy and tolerability profile, making it a trusted choice among healthcare providers for OAB management.
Mysimba (naltrexone HCl and bupropion HCl) extended-release tablets represent a significant advancement in the pharmacological management of chronic weight management in adults. This combination product is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/mΒ² or greater (obesity), or 27 kg/mΒ² or greater (overweight) in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes mellitus, or dyslipidemia.
Reminyl (galantamine hydrobromide) is a prescription medication specifically indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. It belongs to the class of acetylcholinesterase inhibitors and functions as a nicotinic receptor modulator. By increasing acetylcholine levels in the brain and enhancing cholinergic neurotransmission, Reminyl works to mitigate the cognitive decline associated with Alzheimer’s disease, helping patients maintain functional abilities for a longer period. This medication is a critical component in a comprehensive management strategy, often integrated with non-pharmacological interventions to optimize patient outcomes.
Risperdal (risperidone) is an atypical antipsychotic medication approved for the treatment of schizophrenia, bipolar disorder, and irritability associated with autistic disorder. It functions by balancing dopamine and serotonin levels in the brain, offering a targeted mechanism for managing complex psychiatric and behavioral conditions. With a well-established efficacy and safety profile, it remains a cornerstone in modern psychopharmacology for both acute and maintenance therapy. Features Active ingredient: risperidone Available in oral tablets, orally disintegrating tablets, and liquid solution Dosage forms: 0.
Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor (SNRI) approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents, and adults. Unlike traditional stimulant medications, it is not a controlled substance, offering a distinct pharmacological profile with a lower abuse potential. Its mechanism centers on increasing norepinephrine in the prefrontal cortex, a key region for executive functions like attention, impulse control, and organization. This provides a foundational approach to managing core ADHD symptoms throughout the day.
Tamoxifen citrate is a selective estrogen receptor modulator (SERM) representing a cornerstone in the endocrine therapy of hormone receptor-positive breast cancer. It functions as a competitive antagonist of estradiol at estrogen receptors in breast tissue, thereby inhibiting estrogen-dependent proliferation of malignant cells. With decades of clinical use and extensive research, it remains a first-line therapeutic and preventive agent in appropriately selected patient populations. Its well-characterized pharmacokinetic and pharmacodynamic profile allows for predictable efficacy and manageable toxicity under expert supervision.
Tofranil (imipramine hydrochloride) is a tricyclic antidepressant (TCA) with a well-established efficacy profile for managing major depressive disorders, particularly in cases where first-line treatments have proven insufficient. As one of the earliest developed antidepressants, it remains a cornerstone in psychopharmacology due to its robust mechanism of action and predictable therapeutic outcomes. Its use extends beyond depression to several off-label applications, supported by decades of clinical evidence and a deep understanding of its pharmacokinetic properties.
Acamprol (acamprosate calcium) is a clinically validated pharmacotherapy specifically formulated to support abstinence maintenance in alcohol-dependent patients following detoxification. As a synthetic compound with structural similarity to endogenous neurotransmitters, it modulates glutamatergic hyperactivity and GABAergic hypoactivity associated with chronic alcohol exposure. Its targeted mechanism addresses the neuroadaptations underlying craving and withdrawal, offering a physiological foundation for sustained recovery. Acamprol represents an essential component of comprehensive treatment programs when combined with psychosocial interventions.
Accufine represents a significant advancement in the pharmacological management of moderate to severe chronic neuropathic pain. This prescription medication, containing the active ingredient Pregabalin, is specifically formulated to modulate hyperexcited neurons, targeting the underlying pathophysiology of nerve pain rather than merely masking symptoms. Its development is grounded in extensive clinical research, offering a targeted therapeutic option for patients who have found inadequate relief from conventional analgesics. By binding to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, Accufine reduces the release of several neurotransmitters, thereby decreasing neuronal excitability and providing sustained, reliable pain control.